Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 72888-059

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 72888-059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Image (Rabeprazole Dr Tablet 01)

FDA Label Image

Figure 2: Mean Daytime Heartburn Scores Rab-usa-2 (Rabeprazole Dr Tablet 02)

FDA Label Image

Figure 3: Mean Nighttime Heartburn Scores Rab-usa-2 (Rabeprazole Dr Tablet 03)

FDA Label Image

Figure 4: Mean Daytime Heartburn Scores Rab-usa-3 (Rabeprazole Dr Tablet 04)

FDA Label Image

Figure 5: Mean Nighttime Heartburn Scores Rab-usa-3 (Rabeprazole Dr Tablet 05)

FDA Label Image

Rabeprazole Dr Tablets (NDC#72888-059-30)

FDA Label Image

Rabeprazole Dr Tablets (NDC#72888-059-90)

This is a medication description for Rabeprazole Sodium delayed-release tablets with a strength of 20mg. It is distributed by Advagen Pharma Limited and comes in a tight container with 90 tablets. It is manufactured by Rubicon Research Private Limited in India. The medication guide is available and should be dispensed by the pharmacist. The dosage and prescription information can be found in the accompanying prescribing information. The tablets should be stored in temperatures permitted between 15°C-30°C(59°F-86°F) and protected from moisture.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.